Variant report
Variant | nsv961835 |
---|---|
Chromosome Location | chr2:97726182-97732721 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139360400 | chr2:97731843-97731844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201118899 | chr2:97731852-97731853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560352184 | chr2:97731854-97731855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199647438 | chr2:97731863-97731864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574324516 | chr2:97731876-97731877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182621125 | chr2:97731885-97731886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114011318 | chr2:97731887-97731888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532239726 | chr2:97731915-97731916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150025205 | chr2:97731918-97731919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562735526 | chr2:97731957-97731958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531814027 | chr2:97731968-97731969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187046507 | chr2:97731997-97731998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56678113 | chr2:97732030-97732031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182107676 | chr2:97732059-97732060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527643659 | chr2:97732067-97732068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187632803 | chr2:97732072-97732073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527711083 | chr2:97732123-97732124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570803008 | chr2:97732129-97732130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546176339 | chr2:97732139-97732140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372444581 | chr2:97732140-97732141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1148581 | chr2:97732152-97732153 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
22 | rs372955824 | chr2:97732194-97732195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550331919 | chr2:97732198-97732199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376973166 | chr2:97732200-97732201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569053008 | chr2:97732219-97732220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538061546 | chr2:97732226-97732227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141396223 | chr2:97732227-97732228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574686312 | chr2:97732233-97732234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115059376 | chr2:97732343-97732344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533510827 | chr2:97732441-97732442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115955021 | chr2:97732489-97732490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576806857 | chr2:97732498-97732499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373404208 | chr2:97732624-97732625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562263290 | chr2:97732639-97732640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113274049 | chr2:97732717-97732718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:97725400-97726200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr2:97725800-97726200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr2:97725800-97726200 | Enhancers | Ovary | ovary |
4 | chr2:97731800-97732200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:97732000-97732200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr2:97732200-97733200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr2:97732200-97733400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr2:97732600-97734800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |